Corient Private Wealth LP Purchases Shares of 103,425 HCA Healthcare, Inc. $HCA

Corient Private Wealth LP bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, HoldingsChannel.com reports. The fund bought 103,425 shares of the company’s stock, valued at approximately $40,325,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of HCA. Brighton Jones LLC bought a new position in HCA Healthcare during the 4th quarter worth approximately $1,021,000. NewEdge Advisors LLC boosted its stake in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares during the period. Sivia Capital Partners LLC increased its stake in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares during the period. Jump Financial LLC purchased a new position in shares of HCA Healthcare in the second quarter valued at about $2,073,000. Finally, Sei Investments Co. raised its position in HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Down 1.9%

Shares of HCA stock opened at $419.19 on Friday. The company has a 50 day moving average price of $400.24 and a 200-day moving average price of $441.63. The firm has a market capitalization of $90.75 billion, a PE ratio of 14.03, a P/E/G ratio of 1.48 and a beta of 1.10. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.84 earnings per share. Analysts anticipate that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analyst Ratings Changes

Several research analysts have commented on HCA shares. TD Cowen decreased their price objective on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Cantor Fitzgerald decreased their target price on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research note on Tuesday, July 7th. Royal Bank Of Canada reissued an “outperform” rating and issued a $435.00 price target on shares of HCA Healthcare in a research report on Monday, July 27th. Finally, Wells Fargo & Company lifted their price objective on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $462.64.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.